Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.61 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.52 |
| ▸ | TRPM8 | Q7Z2W7 | 8/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.43 |
| ▸ | PAFAH1B2 | P68402 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2569897 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL9079352 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL2576779 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL3979768 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL2184536 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL5035905 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL588839 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL2573332 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL2576370 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 | |
| SCHEMBL3983116 | 1.00 | FAAH (0.61) | FAAHLPAR3LPAR2TRPM8MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760844-B2 | Dispersible antimicrobial complex and coatings therefrom | Poly Group LLC (US) | 2023-09-19 | — | — | US | disclosed |
| CN-116465945-A | Ion-selective membrane, ion-selective electrode, ion sensor, sample testing device, and complex compound | 佳能株式会社 | 2023-07-21 | — | — | CN | disclosed |
| US-20230226544-A1 | ION-SELECTIVE MEMBRANE, ION-SELECTIVE ELECTRODE, ION SENSOR, SPECIMEN TESTING DEVICE, AND COMPLEX COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20220363841-A1 | DISPERSIBLE ANTIMICROBIAL COMPLEX AND COATINGS THEREFROM | Poly Group LLC | 2022-11-17 | — | — | US | disclosed |
| US-20220356309-A1 | DISPERSIBLE ANTIMICROBIAL COMPLEX AND COATINGS THEREFROM | Poly Group LLC | 2022-11-10 | — | — | US | disclosed |
| US-11421084-B2 | Dispersible antimicrobial complex and coatings therefrom | Poly Group LLC (US) | 2022-08-23 | — | — | US | disclosed |
| EP-3144064-B1 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-07-28 | — | — | EP | disclosed |
| US-20200354527-A1 | DISPERSIBLE ANTIMICROBIAL COMPLEX AND COATINGS THEREFROM | Poly Group LLC | 2020-11-12 | — | — | US | disclosed |
| US-20180340046-A1 | DISPERSIBLE ANTIMICROBIAL COMPLEX AND COATINGS THEREFROM | Poly Group LLC | 2018-11-29 | — | — | US | disclosed |
| EP-3377596-A1 | SELECTIVE HYDROGENATION USING A FLOW INDEX | Chevron Phillips Chemical Company LP (US) | 2018-09-26 | — | — | EP | disclosed |
| US-20110213058-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | KANEKA CORPORATION (JP) | 2011-09-01 | — | — | US | disclosed |
| EP-2341106-A1 | CURABLE COMPOSITION AND CURED PRODUCT THEREOF | Kaneka Corporation (JP) | 2011-07-06 | — | — | EP | disclosed |
| WO-2010101736-A2 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-09-10 | — | — | WO | disclosed |
| US-20100228065-A1 | Selective Hydrogenation Catalyst and Methods of Making and Using Same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-09-09 | — | — | US | disclosed |
| CN-100344638-C | Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators | KYORIN SEIYAKU KK (JP) | 2007-10-24 | — | — | CN | disclosed |
| CN-1751054-A | Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators | KYORIN SEIYAKU KK (JP) | 2006-03-22 | — | — | CN | disclosed |
| US-6635683-B1 | Membrane containing onium salt and aromatic boric diester compounds; rapid measurement in body fluids; high sensitivity and selectivity; long life | TOKUYAMA CORPORATION (JP) | 2003-10-21 | — | — | US | disclosed |
| EP-1096251-A1 | FILM RESPONSIVE TO BICARBONATE ION | TOKUYAMA CORPORATION (JP) | 2001-05-02 | — | — | EP | disclosed |
| US-4228020-A | GRAPHITE AND A DI-LOWER ALKYL HYDROCARBYL PHOSPHONATE | EDWIN COOPER, INC. (US) | 1980-10-14 | — | — | US | disclosed |
| US-4003720-A | PHOSPHONIC ACIDS, MOTOR FUELS | TEXACO INC. (US) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760844-B2 | Dispersible antimicrobial complex and coatings therefrom | PICALM, WASF2, SAMM50 | FAAH 3628/4885LPAR3 2894/4885LPAR2 2621/4885 |
| US-20220356309-A1 | DISPERSIBLE ANTIMICROBIAL COMPLEX AND COATINGS THEREFROM | PICALM, WASF2, SAMM50 | FAAH 3628/4885LPAR3 2894/4885LPAR2 2621/4885 |
| US-20230226544-A1 | ION-SELECTIVE MEMBRANE, ION-SELECTIVE ELECTRODE, ION SENSOR, SPECIMEN TESTING DEVICE, AND COMPLEX COMPOUND | LETM1, TIMM9, TMEM109 | FAAH 4523/4885LPAR3 4121/4885LPAR2 3427/4885 |
| US-20220363841-A1 | DISPERSIBLE ANTIMICROBIAL COMPLEX AND COATINGS THEREFROM | PICALM, WASF2, SAMM50 | FAAH 3628/4885LPAR3 2894/4885LPAR2 2621/4885 |
| US-20200354527-A1 | DISPERSIBLE ANTIMICROBIAL COMPLEX AND COATINGS THEREFROM | PICALM, WASF2, SAMM50 | FAAH 3628/4885LPAR3 2894/4885LPAR2 2621/4885 |
| US-11421084-B2 | Dispersible antimicrobial complex and coatings therefrom | PICALM, WASF2, SAMM50 | FAAH 3628/4885LPAR3 2894/4885LPAR2 2621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.